You take your levothyroxine every morning on an empty stomach, exactly as prescribed. You wait thirty minutes before eating. You never miss a dose. And yet you still feel terrible. Your doctor says your TSH is normal, your labs look fine, and maybe you should try exercising more or getting better sleep. But you know something is wrong. If your levothyroxine is not working despite doing everything right, you are far from alone, and the science increasingly suggests that the problem may not be you at all. It may be the medication itself.
Across Canada, hundreds of thousands of hypothyroid patients take levothyroxine (sold as Synthroid or Eltroxin) as their sole thyroid replacement. For many, it works well enough. But for a significant minority, somewhere between ten and fifteen percent of patients, T4-only therapy leaves them stuck in a cycle of persistent symptoms that no dosage adjustment seems to fix. Understanding why this happens, and what you can do about it, starts with understanding how your body actually uses thyroid hormones.
Research Grade · Available in Canada
SRT3-15 Slow Release T3
The T4-to-T3 Conversion Problem
Levothyroxine is a synthetic form of thyroxine, or T4. T4 is the storage form of thyroid hormone. It circulates through your bloodstream in large quantities, but it is essentially inactive. For T4 to do anything useful, your body must convert it into triiodothyronine, or T3, which is the active thyroid hormone that actually enters your cells and drives your metabolism.
This conversion depends on a family of enzymes called deiodinases. The two most important are type 1 deiodinase (DIO1) and type 2 deiodinase (DIO2). DIO2 is particularly critical because it operates inside tissues like the brain, muscles, and brown fat, converting T4 into T3 right where it is needed most. If you want to understand the full picture of how T3 and T4 differ in your body, that distinction between storage hormone and active hormone is the foundation of everything.
When this conversion system works properly, taking levothyroxine provides your body with a steady supply of T4, which your deiodinase enzymes then convert into adequate T3. Your cells get what they need, and you feel well.
But when conversion is impaired, you end up with plenty of T4 in your blood (which makes your TSH look normal on paper) while your tissues are starving for the T3 they actually require. This is where the disconnect between your lab results and your lived experience begins.
Why Your Body May Not Be Converting T4 Properly
Several factors can impair T4-to-T3 conversion, and most of them are invisible on standard blood tests.
The DIO2 Genetic Polymorphism
Research has identified a common genetic variation in the DIO2 gene, known as the Thr92Ala polymorphism, that reduces the efficiency of the DIO2 enzyme. This polymorphism is remarkably prevalent. Studies suggest it affects roughly sixteen percent of the general population in its homozygous form (meaning you inherited the variant from both parents), and an even larger percentage carry at least one copy.
If you have this polymorphism, your DIO2 enzymes work less efficiently at converting T4 into T3 inside your tissues. Your blood levels of T4 and TSH may appear completely normal, but the T3 reaching your brain, muscles, and other organs may be significantly reduced. Published research in the European Journal of Endocrinology has confirmed that standard levothyroxine treatment does not reliably normalise serum T3 levels in hypothyroid patients, even when TSH is brought into range.
Nutritional Deficiencies
The deiodinase enzymes require specific cofactors to function. Selenium is the most critical, as all three deiodinase enzymes are selenoproteins. Zinc and iron also play supporting roles in thyroid hormone metabolism. Deficiencies in any of these nutrients can slow conversion, and they are common in hypothyroid patients, particularly those with Hashimoto's thyroiditis.
Chronic Stress and Cortisol
Elevated cortisol from chronic stress actively suppresses DIO2 activity while upregulating DIO3, the enzyme that converts T4 into reverse T3 rather than active T3. Reverse T3 occupies thyroid receptors without activating them, essentially blocking the action of whatever T3 you do produce. This is one of the most common and most overlooked reasons levothyroxine stops working for people under prolonged stress.
Inflammation and Chronic Illness
Systemic inflammation from autoimmune conditions, gut dysbiosis, or chronic infections also impairs deiodinase activity. Since Hashimoto's thyroiditis is the leading cause of hypothyroidism in Canada and is itself an inflammatory autoimmune condition, many patients are fighting conversion problems driven by the very disease that damaged their thyroid in the first place.
Caloric Restriction and Dieting
If you have been restricting calories to combat the weight gain that often accompanies hypothyroidism, you may be making the conversion problem worse. Your body downregulates T4-to-T3 conversion during caloric deficit as a survival mechanism, preserving energy stores. This creates a frustrating paradox where the harder you try to lose weight, the more your metabolism slows.
The Signs Your Levothyroxine Is Not Working
The symptoms of inadequate T3 at the tissue level are distinctive and persistent. If you recognise several of these despite having a "normal" TSH, poor T4-to-T3 conversion may be the root cause.
Persistent fatigue is the hallmark. Not ordinary tiredness, but a deep, bone-level exhaustion that sleep does not resolve. You wake up feeling as though you never went to bed.
Unexplained weight gain or inability to lose weight despite eating well and exercising. Your metabolism is running on too little active hormone, and your body stubbornly holds onto every calorie.
Brain fog and cognitive difficulties, including trouble concentrating, poor short-term memory, difficulty finding words, and a general sense of mental sluggishness. T3 is critical for brain function, and the brain depends heavily on local DIO2 conversion.
Cold intolerance that goes beyond preference. Your hands and feet are perpetually cold. You wear layers when everyone else is comfortable. Your core body temperature may run consistently low.
Depression and mood changes that do not respond well to antidepressants. T3 has a direct effect on serotonin and other neurotransmitters, and many cases of treatment-resistant depression have underlying thyroid conversion issues.
Hair loss, dry skin, and brittle nails that persist even after your TSH normalises on levothyroxine.
Muscle aches and joint stiffness, particularly in the morning.
Constipation and digestive slowness from reduced metabolic activity in the gut.
If this list reads like a description of your daily life, and your doctor keeps telling you that your TSH is normal so you cannot be hypothyroid, you are experiencing a problem that standard thyroid testing was not designed to catch.
Why Doctors Dismiss Your Symptoms
The standard of care for hypothyroidism in Canada revolves almost entirely around TSH. Your doctor tests your TSH, adjusts your levothyroxine dose until TSH falls within the reference range (typically 0.5 to 4.5 mIU/L), and considers you treated. If you still have symptoms, the default assumption is that the symptoms must be coming from somewhere else.
This approach has a fundamental flaw. TSH reflects how much T4 your pituitary gland is sensing. It does not measure how much T3 is reaching your tissues. You can have a perfectly normal TSH while your cells are chronically undersupplied with the active hormone they need.
Many physicians in Canada do not routinely test free T3, and even fewer test reverse T3. Without these values, there is no way to identify a conversion problem. The research is clear that levothyroxine monotherapy does not reliably restore tissue T3 levels, yet clinical practice has been slow to incorporate this finding.
This is not a criticism of your doctor's intentions. It is a reflection of clinical guidelines that have not yet caught up with the published science. A 2018 review published in Frontiers in Endocrinology acknowledged that combination T4/T3 therapy shows real advantages for a subset of patients, particularly those with the DIO2 polymorphism.
The Case for Adding T3: What the Research Shows
The question of whether adding T3 to levothyroxine improves outcomes has been studied extensively. While early randomised controlled trials produced mixed results (partly due to study design limitations and the use of immediate-release T3, which causes problematic hormone spikes), the broader body of evidence paints a compelling picture.
A landmark 2013 study published in the Journal of Clinical Endocrinology and Metabolism found that patients on combination T4/T3 therapy reported significantly greater satisfaction and preference compared to T4 monotherapy. Patients described improvements in energy, mood, and cognitive function that they had not experienced on levothyroxine alone.
The physiological rationale is straightforward. A healthy human thyroid gland produces both T4 and T3 directly. Approximately eighty percent of circulating T4 comes from the thyroid itself, but the thyroid also secretes T3 directly into the bloodstream, accounting for roughly twenty percent of circulating T3. When you take levothyroxine alone, you are replacing only the T4 component. You are relying entirely on peripheral conversion for all of your T3, which, as we have discussed, does not work adequately for everyone.
Adding a small dose of T3 to your levothyroxine regimen can bypass the conversion bottleneck entirely, delivering active hormone directly to your bloodstream and tissues.
The Problem with Standard T3 Medications
In Canada, the most commonly prescribed T3 medication is liothyronine (brand name Cytomel). While liothyronine does provide T3, it has a significant pharmacological limitation: it is an immediate-release formulation.
When you take immediate-release T3, blood levels spike rapidly within one to two hours, often reaching supraphysiological levels that can cause heart palpitations, anxiety, tremor, and a jittery sensation. These levels then drop off sharply over the next several hours, creating a hormonal roller coaster that many patients find intolerable. This spike-and-crash pattern is also one reason many clinical trials of combination therapy have shown inconsistent results. The delivery mechanism was working against the therapeutic goal.
A healthy thyroid does not dump T3 into your bloodstream all at once. It releases hormone gradually and steadily throughout the day. To properly mimic this, you need a delivery method that matches that natural pattern.
How Slow Release T3 Changes the Equation
Slow release T3 formulations are designed to release triiodothyronine gradually over an extended period, typically eight to twelve hours. Instead of a sharp spike followed by a rapid decline, you get a smooth, sustained curve that more closely mimics what a healthy thyroid produces naturally.
This steady-state delivery offers several advantages over immediate-release liothyronine. It avoids the supraphysiological peaks that cause palpitations and anxiety. It maintains more consistent T3 levels throughout the day, reducing the afternoon crash that many Cytomel users experience. It requires less frequent dosing, often once or twice daily rather than three times daily. And it produces clinical outcomes that better reflect the theoretical benefits of combination therapy.
For Canadians who have struggled with levothyroxine alone, SRT3-15 Slow Release T3 provides a compounded sustained-release formulation that delivers 15 mcg of T3 over an extended period. This approach allows you to add T3 to your existing levothyroxine regimen in a controlled, physiologically appropriate way.
If you are unsure about how to access this type of formulation, our guide on how to get slow release T3 in Canada walks you through the process step by step.
How to Talk to Your Doctor About Adding T3
Approaching your physician about combination therapy requires preparation. Here are practical steps that can make the conversation more productive.
Request comprehensive thyroid testing. Ask for free T4, free T3, reverse T3, and thyroid antibodies in addition to TSH. If your free T3 is in the lower third of the reference range while your free T4 is mid-range or higher, that pattern strongly suggests a conversion problem.
Calculate your free T3 to reverse T3 ratio. A ratio below 0.2 (when free T3 is measured in pg/mL and reverse T3 in ng/dL) suggests that reverse T3 is occupying receptors and blocking T3 action.
Bring published research. The PubMed citations in this article are peer-reviewed and published in respected endocrinology journals. Many physicians are receptive to evidence-based discussions.
Ask about a therapeutic trial. Suggest a three-to-six-month trial of low-dose T3 addition with before-and-after symptom tracking and lab monitoring. This gives both you and your doctor objective data to evaluate.
Document your symptoms. Keep a daily log of your energy levels, body temperature, weight, mood, and cognitive function for at least four weeks before your appointment. Concrete data is harder to dismiss than general complaints.
What to Expect When You Add T3
When T3 is added to levothyroxine therapy appropriately, most patients notice changes within the first two to four weeks. Common early improvements include increased energy and reduced fatigue, improved mental clarity and reduced brain fog, better mood stability, and a slight increase in basal body temperature.
Over the following months, you may also notice improvements in hair growth, skin quality, digestive regularity, and an improved ability to manage your weight. It is important to note that adding T3 typically requires a slight reduction in your levothyroxine dose to maintain proper overall thyroid hormone balance. Your doctor should monitor your labs regularly during the adjustment period.
The goal is not to push your T3 levels high. It is to restore the natural balance between T4 and T3 that your body was designed to operate with, a balance that levothyroxine alone cannot always achieve.
Frequently Asked Questions
Why is my levothyroxine not working?
The most common reason levothyroxine fails to resolve symptoms is impaired T4-to-T3 conversion. Levothyroxine provides only T4, which must be converted into the active hormone T3 by deiodinase enzymes in your tissues. Genetic polymorphisms, nutrient deficiencies (particularly selenium, zinc, and iron), chronic stress, inflammation, and caloric restriction can all impair this conversion. Your TSH may appear normal because your pituitary senses adequate T4, but your cells may not be receiving enough T3 to function properly.
Can I add T3 to my levothyroxine?
Yes. Combination T4/T3 therapy is a recognised treatment approach supported by published research. Adding a small dose of T3 to your existing levothyroxine can bypass conversion problems and deliver active hormone directly. This requires a prescription and medical supervision. A slow release formulation like SRT3-15 is generally preferred over immediate-release liothyronine because it avoids the spike-and-crash pattern that causes side effects.
What are signs of poor T4 to T3 conversion?
The hallmark signs include persistent fatigue despite normal TSH, unexplained weight gain or inability to lose weight, brain fog and cognitive difficulties, cold intolerance, depression that does not respond to antidepressants, hair loss, dry skin, constipation, and muscle aches. On blood work, the pattern typically shows a free T3 level in the lower portion of the reference range, a free T4 level that is mid-range or higher, and often an elevated reverse T3 level.
What is the DIO2 gene polymorphism?
The DIO2 Thr92Ala polymorphism is a genetic variation that reduces the efficiency of the type 2 deiodinase enzyme, the primary enzyme responsible for converting T4 into T3 inside your tissues. Approximately sixteen percent of the population carries two copies of this variant. Research has shown that individuals with this polymorphism may respond better to combination T4/T3 therapy than to levothyroxine alone, because their bodies are less capable of generating sufficient T3 from T4.
Is slow release T3 better than Cytomel?
For most patients, slow release T3 offers significant advantages over immediate-release liothyronine (Cytomel). Cytomel causes rapid spikes in blood T3 levels that can trigger palpitations, anxiety, and tremor, followed by a sharp decline that leaves you feeling depleted. Slow release T3 delivers the hormone gradually over eight to twelve hours, producing a smoother, more physiological curve. This steadier delivery reduces side effects and maintains more consistent energy throughout the day.
Will my doctor prescribe T3 in Canada?
Many Canadian physicians are open to combination therapy when presented with evidence of a conversion problem. Having comprehensive lab work (including free T3 and reverse T3), documented symptoms, and published research to reference significantly improves your chances. Some endocrinologists and integrative medicine practitioners are already familiar with this approach. If your current physician is not receptive, seeking a second opinion from a provider experienced in thyroid optimisation may be worthwhile.
How long does it take for T3 to start working?
Most patients notice initial improvements within two to four weeks of adding T3. Energy and mental clarity tend to improve first, followed by mood stabilisation. Physical changes such as improved hair growth, skin quality, and metabolic rate may take two to three months to become apparent. Full optimisation, including lab stabilisation and dosage fine-tuning, typically takes three to six months.
Can poor T4 to T3 conversion cause weight gain?
Absolutely. T3 is the hormone that directly regulates your metabolic rate. When your cells do not receive adequate T3, your basal metabolic rate drops, meaning you burn fewer calories at rest. Your body also becomes more efficient at storing fat and more resistant to releasing it. This is why many hypothyroid patients on levothyroxine alone find it nearly impossible to lose weight despite strict dieting and regular exercise. Restoring adequate T3 levels can help normalise metabolic function and make weight management achievable again.
Moving Forward
If your levothyroxine is not working and your doctor keeps telling you that your labs are normal, you are not imagining your symptoms. The science is clear that T4-only therapy does not work for everyone, and the reasons are well-documented in the medical literature. Genetic variations, nutrient deficiencies, stress, and inflammation can all prevent your body from converting the T4 in levothyroxine into the T3 your cells actually need.
Adding T3 through a slow release formulation offers a path forward that addresses the root cause rather than masking the symptoms. It is not about abandoning levothyroxine. It is about completing the picture by providing the active hormone that your body cannot adequately produce on its own.
You deserve to feel well, not just to have normal-looking lab results. The gap between those two things is exactly where T3 therapy lives, and for many Canadians, it has been the missing piece that finally made the difference.